Next Article in Journal
Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV
Previous Article in Journal
A Low-Molecular-Weight Polyethylenimine/pDNA-VEGF Polyplex System Constructed in a One-Pot Manner for Hindlimb Ischemia Therapy
Open AccessMeeting Report

Age-Related Medicine

1
Academy of Pharmaceutical Sciences, 4 Heydon Road, Great Chishill, Royston, Herts SG8 8SR, UK
2
Department of Pharmaceutics, School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK
3
Effective Prescribing and Therapeutics, Health and Social Care Directorate, Scottish Government, Edinburgh EH6 5NL, Scotland, UK
4
Institute of Process and Particle Engineering, Graz University of Technology, Inffeldgasse 13, 8010 Graz, Austria
5
Medicines Evaluation Board in the Netherlands, Quality Department, Chemical Pharmaceutical Assessments, P.O. Box 8275, 3503 RG Utrecht, The Netherlands
*
Author to whom correspondence should be addressed.
Pharmaceutics 2019, 11(4), 172; https://doi.org/10.3390/pharmaceutics11040172
Received: 31 March 2019 / Accepted: 2 April 2019 / Published: 9 April 2019
A meeting organised by the Academy of Pharmaceutical Sciences focussed on the challenges of developing medicines for older adults. International experts discussed the complexity introduced by polypharmacy and multiple morbidities and how the risk–benefit ratio of a medicine changes as an individual ages. The way in which regulatory authorities are encouraging the development of age-appropriate medicines was highlighted. Examples were provided of the difficulties faced by the older population with some medicinal products and suggestions given as to how the pharmaceutical scientist can build the requirements of the older population into their development of new medicines, as well as improvements to existing ones. View Full-Text
Keywords: polypharmacy; multiple morbidities; ageing; pharmaceutical sciences; product development; SIMPATHY polypharmacy; multiple morbidities; ageing; pharmaceutical sciences; product development; SIMPATHY
MDPI and ACS Style

Wahlich, J.; Orlu, M.; Mair, A.; Stegemann, S.; van Riet-Nales, D. Age-Related Medicine. Pharmaceutics 2019, 11, 172.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop